Testing PRAX-628 for adults with focal seizures
Part of Brain & nervous system clinical trials.
This trial tests an investigational drug called PRAX-628 in adults whose seizures start in one part of the brain (focal seizures). The goal is to see if the drug is safe and works better than a placebo at reducing seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of focal onset epilepsy (seizures that start in one area of the brain).
- You have had a CT or MRI scan that shows your epilepsy is not caused by a progressive disease.
- You have not had certain types of seizures in the past year, like seizures that can't be counted or a severe prolonged seizure needing a breathing tube.
- You are not planning to have epilepsy surgery during the study.
- You do not have a history of schizophrenia, obsessive-compulsive disorder, or other serious mental health conditions.
- You have not had cancer or certain blood disorders in the last 5 years, and you do not have serious heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called RAP-219 can help adults with focal seizures (seizures that start in one area of the brain) control their seizures better. You would take this medication alongside your current seizure drugs for about 12 weeks.
This study tests a new medication called RAP-219 to see if it can reduce seizure frequency in adults with focal epilepsy (seizures starting in one area of the brain). You'll take the medication alongside your current seizure drugs and track your seizures daily using an app.
This study tests an experimental pill called PRAX-628 for adults whose seizures are not fully controlled by current medications. It aims to see if the drug is safe and effective at reducing seizures.
This study tests a new medicine called BHV-7000 for adults whose focal seizures (starting in one part of the brain) are not controlled by current treatments. The goal is to see if it can reduce seizures safely.
This trial tests XEN1101 compared with a placebo (inactive pill) in people with focal-onset seizures that haven’t been fully controlled despite trying at least two anti-seizure medicines. If you qualify, you may help researchers see whether the study drug reduces seizure frequency and improves control.
This study tests an investigational drug called SPN-817 to see if it can reduce focal seizures (seizures that start in one area of the brain) in adults whose seizures are not well controlled by current medications.
Hear when a new Focal Seizure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.